Analystreport

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) had its price target raised by analysts at Wedbush from $9.00 to $28.00.

FIVE PRIME THERAPEUTICS  (FPRX) 
Last five prime therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.fiveprime.com/investor-relations